Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. - Wikidata - awgldk - TriplyDB

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

http://www.wikidata.org/entity/Q34592481

about

Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Metalloprotein-based MRI probes A Histidine Aspartate Ionic Lock Gates the Iron Passage in Miniferritins from Mycobacterium smegmatis Re-engineering protein interfaces yields copper-inducible ferritin cage assembly Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as a potential anticancer agent of the Auoxo3-loaded protein Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells Magnetoferritin nanoparticles for targeting and visualizing tumour tissues Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.Targeted delivery of a photosensitizer to Aggregatibacter actinomycetemcomitans biofilm.Multivalent viral capsids with internal cargo for fibrin imaging.Native and synthetic ferritins for nanobiomedical applications: recent advances and new perspectives.Use of human amelogenin in molecular encapsulation for the design of pH responsive microparticles.Magnetic Resonance Imaging Tracking of Graft Survival in the Infarcted Heart: Iron Oxide Particles Versus Ferritin Overexpression Approach Intrinsically radiolabeled nanoparticles: an emerging paradigm.H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.Human ferritin cages for imaging vascular macrophages Chimeric ferritin nanocages for multiple function loading and multimodal imaging.X-ray spatial frequency heterodyne imaging of protein-based nanobubble contrast agents.RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors Ferritin protein nanocages use ion channels, catalytic sites, and nucleation channels to manage iron/oxygen chemistry.Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size.Random mutagenesis of amelogenin for engineering protein nanoparticles.Aptamer-modified nanodrug delivery systems Development of virus-like particles for diagnostic and prophylactic biomedical applications Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles.Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T1 contrast agent for high-field MRI Temperature dependence of electron magnetic resonance spectra of iron oxide nanoparticles mineralized in Listeria innocua protein cages Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells Hybrid ferritin nanoparticles as activatable probes for tumor imaging Ferritins as nanoplatforms for imaging and drug delivery Size and crystallinity in protein-templated inorganic nanoparticles.Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.Synthesis of a cross-linked branched polymer network in the interior of a protein cage.Chaperonin-Dendrimer Conjugates for siRNA Delivery.Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex.Targeting cancer with 'smart bombs': equipping plant virus nanoparticles for a 'seek and destroy' mission.Superparamagnetic Nanoparticles for Atherosclerosis Imaging RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease

P2860

Q24599399-0A523661-D80D-4D44-8E49-CBBAAC8BD745 Q26849668-D0CB8097-AC1B-4560-891E-563AEA800E0E Q27681922-864884C4-D9D6-40D0-BCFC-AD0280F1226C Q27683807-24A3DB6B-1250-4AF8-923D-8FB567CE52BB Q27704043-792BF805-1C60-4E14-99FE-508565B3A478 Q27712597-0163AE4E-52DD-499F-8F20-9C26F6864B81 Q28817539-1F4B73BF-4949-4092-9FFC-5778E66B12FD Q29400779-CF947446-C0A1-4A86-A70B-E1B23791EE3B Q33514896-75E63FCB-6DB3-4809-A757-C9202E6CA0A9 Q33553068-758133A8-B870-45B8-90A7-4128398A83AD Q33800320-36738144-F39A-48F4-A5BD-C3ACA3E8E5FF Q33852368-FDBC4714-BA05-4752-90AC-3917446E65DB Q34282480-B63D7742-2E41-47B6-B152-CFD3F8C53DBC Q34288149-14764AA2-32E3-4E56-9CCD-5D06DC568553 Q34315359-F9570CEA-424C-4EF7-AA08-6CAA2F53966C Q34383748-4175ED8A-0F80-436D-9224-E0238090E958 Q34452433-0841851C-3B5E-426C-A9B1-B92784E45C23 Q34565032-A3A23083-F88E-4221-BB77-6F0895A435F8 Q34584613-FD5C0443-A9D3-42FE-80EE-620CA338285C Q34652361-9AEE6492-29DB-422A-96C8-2D2B5FA8CE01 Q34778885-F110B19F-2548-4CDD-993E-7351B5E2C899 Q34861181-33E81384-C8C2-4F2A-83C5-2906CFE0A9B9 Q35298245-79163AD8-063A-40C9-AA3B-1EE883EED531 Q35558223-16AF8257-9F05-4243-ABB2-03D32E6901A2 Q35633429-DEB33C3C-2890-4ACA-B3F6-F96517A11A35 Q35889469-4FD02BE8-8B34-41E1-BC75-1A9F51D9D7EB Q35972603-1E626466-AECB-4F06-8FE6-079CF863C464 Q36192560-6F0B8293-D22B-4DCA-9F20-61CD34FF4590 Q36367848-E6FB6467-B458-4C29-8BFC-0C19F3EA87BC Q36540861-18065B02-8BD1-4A66-BAC6-DFFC2A4EC626 Q36777388-3977DE50-BAC7-42EA-8A15-C4D9BF5A5914 Q36948081-F5799BED-15C1-4087-BBEB-D8F65B4A43E6 Q37131192-557CE46D-D67D-4E11-A110-4429C92F129E Q37319940-EAD8C38D-A2AC-4496-BDF2-1BF631EFBC48 Q37363194-9B473C24-E23E-4A14-AC5E-85DE461861F8 Q37394496-14F26611-036F-4FB7-86E2-B254D3A4214C Q37428069-560FB7FC-147D-4B2E-A43A-3306959F60D6 Q37538780-AFD5B350-F556-477F-A2DC-1B5A8CF4A7E7 Q37638513-08ADEAFC-30DC-4673-95F9-6A166221C5C1 Q37658548-75E23757-8B07-4392-94D1-59BE50D23586

P2860

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

http://www.wikidata.org/entity/Q34592481

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@en

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@nl

type

label

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@en

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@nl

prefLabel

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@en

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@nl

P1433

Q34592481-9B272C50-8FB7-492C-A58F-8F191F3BA973

P1476

Q34592481-D6A0AA2C-91E6-417F-A2D0-737102906921

P2093

Q34592481-1224031A-E12F-42BB-B701-A1B49584FC66

Q34592481-42084B9E-2C19-4373-9E2F-1D33266F5085

Q34592481-4455EBFA-793A-4C92-9034-14105EDCC908

Q34592481-5FD1F6EF-D42F-4A48-9062-A1298E72601A

Q34592481-63EA0956-103F-42E4-8581-C3207DB25CE1

Q34592481-6676DDF2-D173-49B2-8DC6-164AF3B8901B

Q34592481-9A2C197A-4EF3-4E5A-B84E-563DEF33208C

Q34592481-AD61F18A-3586-49E9-A5D6-ABDE968A8437

Q34592481-E6C9F3D3-5D1F-41BE-AC05-3F3B4C84FDA4

Q34592481-FA7B7BF3-A599-437A-B058-1E7E0C8498BA

P304

Q34592481-0F5FB936-05E9-4E73-A641-C819FF2B9AE0

P31

Q34592481-AED1E9F4-C97C-481E-AF28-9F76CF40D931

P356

Q34592481-FCBBB0E6-A6F9-4A1D-B9D4-48AE65ED2AD3

P407

Q34592481-781F9D72-2CE0-4E4E-9923-619227B84786

P433

Q34592481-EF325251-4437-45C1-90C5-9336E05F716C

P478

Q34592481-72594E41-EE0C-4F3D-9628-199FFB80C00C

P50

Q34592481-ECB821BF-264F-4974-857A-D6EA9888EB04

P577

Q34592481-63350BEF-80B8-41DD-A106-64C8368343CB

P698

Q34592481-F95B5DF7-1436-4A5A-92AB-67A8CF4D2C74

P921

Q34592481-FF88249E-2493-4536-950B-56F7F3568B6D

P356

P1433

Journal of the American Chemical Society

P1476

Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles.

@en

P2093

Ann F Willis

http://www.w3.org/2001/XMLSchema#string

Bridgid E Crowley

http://www.w3.org/2001/XMLSchema#string

Deborah A Willits

http://www.w3.org/2001/XMLSchema#string

Larissa Jackiw

http://www.w3.org/2001/XMLSchema#string

Mark Allen

http://www.w3.org/2001/XMLSchema#string

Mark J Young

http://www.w3.org/2001/XMLSchema#string

Mark Jutila

http://www.w3.org/2001/XMLSchema#string

Michelle L Flenniken

http://www.w3.org/2001/XMLSchema#string

Susan Brumfield

http://www.w3.org/2001/XMLSchema#string

Trevor Douglas

http://www.w3.org/2001/XMLSchema#string

P304

16626-16633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JA0655690

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17177411

http://www.w3.org/2001/XMLSchema#string

P921